Introduction
We have previously shown that an autologous anti-idiotype, an antibody to anti-bovine casein, can be isolated from the sera of patients with selective IgA deficiency (1) . About onehalf of individuals having this deficiency can be demonstrated to have an excessive absorption of food protein from the intestinal tract and high levels of antibodies to these substances, presumably due to the absence of secretory IgA (2) (3) . Further antigen ingestion leads to formation of circulating immune complexes (3) (4) (5) , and in previous studies we have shown that bovine antigens are important constituents of these complexes Address correspondence to Dr. Cunningham-Rundles, Memorial SloanKettering Cancer Center.
Received for publication 30 July 1984 and in revised form 14 December 1984. (6) . Since systemic immunization with antigen-antibody complexes has been shown to be a very effective means of producing anti-idiotypic antibodies in animal systems (7), we previously sought anti-anti-bovine casein antibodies in the sera of IgA-deficient patients. Antibodies with specific activity for the casein binding site of anti-casein antibodies were subsequently isolated (1) .
In these studies we show that an autologous anti-idiotype, anti-anti-casein, identifies similar antigenic regions to a specifically raised heterologous anti-anti-casein and that using both reagents, the anti-caseins of unrelated IgA-deficient donors can be shown to share common antigenic determinants that are located both within and outside the antigen binding site.
Methods
Anti-casein antibodies. Sera or plasma of 16 adult patients with selective IgA deficiency were obtained from the Immunodeficiency Clinic of the Memorial Sloan-Kettering Cancer Center (12 donors) and the Finnish Red Cross (4 donors). Three of the North American donors were related (A., C., and L. Lun); all other donors were unrelated. The serum of a normal male donor (Geb) with a high level of anti-casein antibody was also used. Anti-casein antibodies were isolated from sera by affinity chromatography as previously described (1) . Anti-casein IgG was subsequently purified by passage over DEAE cellulose (Bio-Rad Laboratories, Richmond, CA) equilibrated in 0.01 M Na phosphate buffer, pH 7.1. This step also removes casein, which is adherent to cellulose under these conditions (1) . Anti-casein was evaluated by enzyme-linked immunosorbent assay (ELISA)' (4), and specific anti-casein activity was expressed as 405 nm/mg IgG OD. IgG was quantitated by spectrophotometric reading at 280 m (DU-8; Beckman Laboratories, Irvine, CA) or by ELISA with sensitivity to 0.1 ng. The plasma of the IgA-deficient Finnish donor, Rei, having the highest anti-casein activity, was used as a source of anti-casein used in rabbit immunizations and for isolation of an autologous anti-anti-casein. F(ab'2 fragments of Rei anti-casein IgG were prepared by pepsin digestion (1, 8) ; residual Fc fragments and intact IgG were removed by absorption with S. aureus (1) . The purity of the F(ab32 fraction was tested by electrophoresis on 10% SDS-polyacrylamide gels.
Isolation of autologous anti-anti-casein. Anti-anti-casein, the autologous anti-idiotype, was isolated from the DEAE-purified IgG fraction of Rei's plasma that did not adhere to casein-Sepharose by a second passage over Sepharose 4B, to which I mg/ml of Rei anticasein IgG was coupled (1). The adherent fraction was collected by elution of 0.1 M glycine-HCI buffer, pH 2.7. Anti-anti-casein activity was assayed by an inhibition ELISA (1) as described below.
Preparation of rabbit antisera to anti-casein. Two white male Hartley rabbits were tolerated to pooled human IgG (HIgG) by two intravenous injections of 10 mg (in I ml NS) of deaggregated pooled HIgG given 3 wk apart (9). The tolerated rabbits were then given 3 i.v. injections of Rei anti-casein-casein immune complexes prepared by incubation of these components at an antigen-antibody ratio of 1: 10 at 370C for I h and then at 4VC overnight. 20 Mg of anti-casein IgG were used to prepare immune complexes for the first immunization, and 50 Mg for the immune complexes for the second and third injections given 2 and 4 wk later. The rabbits were bled 3 wk after the last injection. The 50% (NHI4)SO4 precipitated fractions of these sera were absorbed by passage over pooled HIgG and then casein Sepharose affinity columns. Potential antibodies to Rei anti-casein were isolated from fractions not adhering to these columns by a further passage over Sepharose to which Rei anti-casein was attached (1). Antibodies were then tested for anti-idiotypic activity by inhibition ELISA (see below). The antiserum of rabbit 3934, having the highest activity, was used in the following studies.
Assay (b) Preparation ofalkaline phosphatase-labeled casein. Purified Na caseinate was coupled to AP at an enzyme protein ratio of 1:2 (1).
The aggregates were collected in the void volume from an Ultragel ACA 22 column. The conjugate was then used at a dilution of 1:100 in PBS-Tween 20.
Immunoglobulin fractions. Myeloma proteins Chr (IgG,xK), Fre (IgG1,), Bau (IgG2,K), Gui (IgG2,X), Hac (IgG3,K), Jor (IgG3,X), and Pen (IgG4,K) were gifts from Dr. G. Litman. The IgG fraction of pooled human gammaglobulin (Gamastan, Cutter Laboratories, Berkeley, CA) was purified by passage over DEAE cellulose and equilibrated in 0.01 Na phosphate buffer, pH 7.1 (11). The IgG fraction was extensively dialyzed vs. water, lyophilized, and reconstituted in PBS at 10 mg/ml. IgG aggregates were removed by centrifugation at 1,000 g (IEC-PRJ, Damon, PA) at 4VC for 10 minutes. The deaggregated portion was removed from the top third of the supernatant. This material was used for tolerization of rabbits to HIgG and as a control in all experiments. Quantitation of IgG was determined by spectrophotometric readings at 280 nm OD using extinction coefficient of 1.2 or by ELISA with sensitivity to 0.1 ng/ml.
Results
Anti-idiotypic activity ofautologous anti-anti-casein. The antiidiotypic activity of potential anti-anti-caseins isolated from Rei serum was determined by inhibition ELISA (1). As shown in Fig. 1 Anti-idiotypic activity of rabbit anti-anti-casein. As in the above ELISA, increasing amounts of the rabbit anti-idiotype also increasingly blocked the binding of AP-casein to both intact (Fig. 2 A) and F(ab')2 fragments (Fig. 2 B) The results for experiments using the autologous anti-anticasein are shown in Fig. 5 A and that for heterologous antianti-casein in Fig. 5 B. For each anti-casein IgG, the relative amount of inhibition produced was expressed as a percentage of the inhibition produced by nonlabeled Rei anti-casein IgG, which in both experiments was found to produce maximum inhibition. The PBS coated tubes produced very low absorbance, which was similar to the results for wells coated with four myelomas or pooled human IgG. Of the sera tested, Kar, Tap, Rei, and Ket were from donors of Finnish ancestry; the remaining sera were derived from North American donors of diverse ancestry. In the assay using the autologous anti-anticasein (Fig. 5 A) , anti-caseins of the Finnish sera, Kar and Ket, and those of the Americans (Nat -and Lau) produced significant inhibition (>50%), while the remaining anti-caseins, including that of Geb, the normal donor, produced <50% inhibition.
Using the heterologous anti-anti-casein, anti-casein IgG from the sera of Ket, Lau, Kar, Tap, and Wei inhibited by 75% or more the binding of Rei anti-caseins to the rabbit antiidiotype. Of these, Ket, Kar, and Tap were Finnish donors. An intermediate level of inhibition (50-75%) was found for the anti-caseins of Ier, Ruf, Win, Gaf, Nat, and McK, while anti-caseins from C. Lun, L. Lun, Sil, and A. Lun, and Geb (the normal donor), produced <50% inhibition.
In Fig. 5 and heterologous anti-idiotype to anti-casein, we found that both the isolated autologous anti-anti-casein and the rabbit anti-anti-casein bound either intact or F(ab')2 fragments of Rei anti-casein in the region of the antigen-binding site, since they prevented the binding of casein to anti-casein. In addition, the finding that both the autologous and heterologous antiidiotypes compete with each other for binding to anti-asein, demonstrates that the determinants they recognize may be similar, although the effects of steric hindrance in this experiment make it impossible to draw firm conclusions. In the antigen competition assay, casein appeared to block more completely the binding of anti-casein to the autologous antiidiotype than to the heterologous anti-idiotype, which implies that a greater number of nonsite-directed antibodies could be present in the heterologous as opposed to the autologous antisera. This is in agreement with murine studies that show that a higher proportion of nonsite-directed vs. site-directed anti-idiotypes are produced when the immunizing antibody is more saturated with antigen (12). These differences might be due to immunization, since the heterologous anti-idiotype was prepared by immunization with immune complexes at an antibody/antigen ratio of 1:10, and the autologous anti-idiotype was isolated from the serum of an IgA-deficient individual who has a variable saturation of anti-casein with casein (depending on diet, references 4 and 5). Another reason for the inability of casein to block completely the interaction between idiotype and the anti-idiotype could be the presence of antibody to nonidiotypic determinants in the autologous and heterologous anti-idiotypes. Such antibodies could be directed at framework, hinge, or other F(ab) determinants. This possibility seems less likely since neither the autologous nor the heterol-ogous anti-idiotypes bound pooled human IgG or a panel of various myeloma proteins. In addition, the use of a nonrelevant rabbit anti-idiotype anti-anti-tetanus produced no effects in these experiments.
Using these anti-idiotypes in an assay used to identify CRI between the isolated anti-caseins of unrelated and ethnically diverse IgA-deficient donors, we found that 6 of 16 were crossreactive using the autologous anti-idiotype, and that the same six, plus an additional six anti-caseins, were cross-reactive using the heterologous anti-idiotype. These findings indicate that anti-caseins share several common idiotypes, with the rabbit antisera having the capacity to recognize a broader spectrum of cross-reactive determinants than the autologous anti-anti-casein. For the reasons discussed above, it is not possible to exclude completely the possibility that some of the determinants recognized (particularly by the heterologous group) may be nonidiotypic, but the inability of pooled human IgG, or six IgG myelomas of various heavy and light chain class to inhibit this binding indicates that these results are more likely to be due to idiotypic cross-reactivity.
Cross-reactive idiotypes have been described in the sera of mice (13) (14) (15) (16) (17) (18) (19) , rabbits (20) (21) (22) , guinea pigs (23) , and man (24-34). Although there are numerous reports for such crossreactivities in animals, in man, fewer reports exist, and these have been predominantly amongst antibodies isolated from sera of individuals having autoimmune disease (24-33). The results of this study affirm the possibility that antibodies directed to external antigens may also share CRI.
One reason for the production of CRI could be the presence of a limited number of antigenic epitopes on casein. This factor may be involved in the sharing of idiotypes observed amongst anti-thyroglobulins (30, 34) and anti-ssDNA antibodies (31) . The number of antigenic epitopes on bovine casein is unknown, but since casein is a family of proteins of varying molecular weights (12,000-24,000) with a range of electrophoretic mobilities (35) , it appears improbable that epitope restriction could be responsible for the cross-reactivities observed here.
Another reason for the observed cross-reactive idiotypes could involve the nature of the patients studied. Since IgAdeficient individuals already share defects in IgA production, it is possible that certain V restrictions linked to this defect could be present. In addition, it is known that HLA A1, B8, and particularly DR3 are present in increased frequency in IgA-deficient individuals (36) . One might speculate that the genetic expression of this DR locus could be associated with particular VH genes governing selected idiotypic determinants. Studies to determine whether this is true in the population studied here are underway; however, of the two North American IgA-deficient donors who shared CRI (using the autologous reagent), neither were HLA, B1, B8, or DR3, nor did they share any common DR type.
In summary, this data shows that antibodies of similar specificity, isolated from IgA-deficient human sera, can share CRI and that sharing of CRI is particularly common for Finnish donors. The reasons for this restriction of immunoglobulin heterogeneity are unknown, but this system may be useful in the elucidation of V region inheritance in man.
